R Noyon

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

Flora E. van Leeuwen, Willem J. Klokman, Anton Hagenbeek et al. · Journal of Clinical Oncology · 1994 · 449 citations

Medicine, Oncology, Pathology +14

Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.

Flora E. van Leeuwen, Anne M. Stiggelbout, Alexandra W. van den Belt‐Dusebout et al. · Journal of Clinical Oncology · 1993 · 253 citations

Medicine, Oncology, Pathology +14

Roles of Radiotherapy and Smoking in Lung Cancer Following Hodgkin's Disease

Flora E. van Leeuwen, Willem J. Klokman, Marilyn Stovall et al. · JNCI Journal of the National Cancer Institute · 1995 · 237 citations

Medicine, Oncology, Radiation Oncology +17

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.

Flora E. van Leeuwen, A.M.J. Chorus, Alexandra W. van den Belt‐Dusebout et al. · Journal of Clinical Oncology · 1994 · 194 citations · Full text

Medicine, Oncology, Pharmacology +15

Roles of Radiotherapy and Chemotherapy in the Development of Contralateral Breast Cancer

Maartje J. Hooning, Berthe M.P. Aleman, Michael Hauptmann et al. · Journal of Clinical Oncology · 2008 · 113 citations

Medicine, Oncology, Radiation Oncology +16